CClinicalTrials.gg
Status unknownNCT01131663Updated May 27, 2010

Design and Development of an Infant's Oriented Face Mask

An observational study in Infant, sponsored by Ziv Hospital. Status unknown at 2 sites in Israel. Open to participants aged Up to 4 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2010-05-27.

Sponsored by Ziv Hospital · Observational

The sponsor has not verified this record recently (last verified May 2010), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
200
Ages
Up to 4 Years
Sex
All
01

Study summary

Face masks are used for many respiratory care applications such as anaesthesia, resuscitation, and aerosol therapy. None of the currently available face mask for infants and young children are specifically designed and developed for infants. The aim of this study is to design, develop and test the first infant's oriented face mask.

To achieve this ultimate goal we will first define appropriate sizes of infants' faces that would be used as templates for the design and development of optimally fitted model masks. In the next stage we will use these masks and incorporate the infants' own soother (pacifier) into a new SootherMask (SM). In the last part of the study we will compare acceptance levels between Soothermask (SM) and a conventional commodity masks without a pacifier.

Read the detailed description

Not all face masks are "born equal" and care must be taken in mask design, particularly for the early pediatric age group. Unfortunately, facemasks provided for infants and young children have been merely smaller versions of those used for adults with little consideration given to their special needs

We believe that a major advance in answering the needs of infants rely in making the mask more friendly user by making sucking on the infant's soother an integral part of the newly developed mask. This is based on the following premises:

  1. Sucking is a vital feeding and soothing activity of infants. Incorporating sucking into the act of aerosol delivery greatly reduces the fear engendered and inconvenience of putting an obtrusive mask on the infant's face.
  2. Linking the mask to the sucking action ensures a tight seal between the mask and the face. Every time the baby sucks on the pacifier or the bottle nipple, the mask is pressed onto the face by atmospheric pressure thus ensuring a good mask to face seal. This then also ensures that the aerosol that has been sprayed into the holding chamber will be drawn into the baby's lungs through the nose with each inspiration.
  3. The material of the mask's rim is relatively wide, soft, corrugated and is thus highly flexible. This makes the mask easily compressible without overdue force on the infant's face. Thus, the act of sucking attracts the mask to the child's face, assists in achieving a good seal and compresses it thus substantially reducing the dead space volume of the mask.

The ultimate goal of the present study is to answer these specific needs of infants and to develop an appropriate infant's oriented face mask. In order to achieve this goal the study will have three specific objectives.

Objective #1 Define morphometric data of infants' faces Objective #2 Design and develop an optimally adapted face mask SootherMask (SM) based on the morphometric results Objective #3 Compare the acceptance levels between Soothermask (SM) and a conventional commonly used masks without a pacifier.

02

Conditions studied

  • Infant

Keywords

  • Infants, aerosol, acceptance, face mask, drug delivery
03

In context

Lead sponsor

Ziv Hospital is the lead sponsor of 82 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 4 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

hospitals,primary care clinic, community sample

Inclusion criteria

Signed informed consent

Exclusion criteria

Exclusion Criteria:

Non cooperation with procedure

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
200 participants (estimated)
06

What researchers measure

Primary outcomes

  1. Acceptance levels of new infant face mask

    Infants will be offered two sets of simulated treatment options at random order: Placebo treatment by nebulizer (half the group) or by Valved Holding Chamber (VHC) (the other half) through the SM followed by placebo treatment by nebulizer (half the group) or by VHC (the other half) through the conventional mask. Treatments will be done sequentially at random order while the procedure is being captured and recorded on video. The video clips will be analyzed later off site and will be coded according to the scale in the scoring form to compare between acceptance levels of the two face masks.

    Time frame: 10 minutes

07

Study locations

2 of 2 sites recruiting
  • Ziv Medical center
    Safed, 13100, Israel
    • Israel Amirav, MD · Principal investigator
    Recruiting
  • Pediatric Department, Ziv Medical Center
    Safed, Israel
    • Israel Amirav, MD · Contact · amirav@012.net.il · 9726828712
    • Israel Amirav, MD · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 27, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01131663
Lead sponsor
Ziv Hospital
First posted
May 27, 2010
Start date
Apr 2010
Primary completion
Apr 2011 (estimated)
Completion
Apr 2012 (estimated)
Last update
May 27, 2010

Study contacts

Israel Amirav, MD
Contact
amirav@012.net.il
97246828712
Israel Amirav, MD
principal investigator · Ziv Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion